Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Despoina Papakosta is active.

Publication


Featured researches published by Despoina Papakosta.


Allergy | 2004

Allergenic pollen records (15 years) and sensitization in patients with respiratory allergy in Thessaloniki, Greece

Dimitrios Gioulekas; Despoina Papakosta; Athanasios Damialis; F. Spieksma; P. Giouleka; D. Patakas

Background:  Very limited allergenic pollen records exist in Greece so far; moreover, there is a lack of investigation on patient sensitization. The above data are necessary for respiratory allergy diagnosis and treatment worldwide.


International Journal of Pharmaceutics | 2014

Experimentation with inhaled bronchodilators and corticosteroids

Paul Zarogoulidis; Konstantinos Porpodis; Ioannis Kioumis; Dimitris Petridis; Sofia Lampaki; Dionysios Spyratos; Antonis Papaiwannou; John Organtzis; Theodoros Kontakiotis; Katerina Manika; Kaid Darwiche; Lutz Freitag; Theodora Tsiouda; Despoina Papakosta; Konstantinos Zarogoulidis

BACKGROUND Inhaled bronchodilators and corticosteroids have been used for decades with different production systems. MATERIALS AND METHODS The following jet-nebulizers: (a) Invacare, (b) Sunmist, (c) Maxineb and ultrasound nebulizers: (a) GIMA, (b) OMRON and (c) EASY NEB II were used as production systems. The jet-nebulizers were used with different residual cups and volume filling, while the ultrasound nebulizers with different volume fillings and face mask versus inlet. RESULTS Inhalation and ultrasound process detect significant differences between the factors and interactions considered, but each technique follows a specific pattern of magnitude effect. Thus the inhaled mechanism ranks the factor effects in decreasing order: residual cup>drug>nebulizer>loading (2, 3, 4 ml) and also drug>residual cup>nebulizer (loading 8 ml). The ultrasound mechanism orders as follows: nebulizer>drug>loading. In fact, varying micro environmental conditions created during the performance of the devices in both processes alternate the magnitude of factor significance allowing for unique capacities. CONCLUSIONS PULMICORT, MAXINEB, design cup J and loading 6 ml are the best options for the inhaled process. Optimal combinations are provided by FLIXOTIDE and cup B and also by MAXINEB and cup J. The incorporation of large residual cups suggests one out of six drugs, the SUNMIST nebulizer and design D as the best choices. Ultrasound performance informs for other optimal conditions: ZYLOREN, MAXINEB, 4 ml load and MAXINEB×loading 4 ml.


Allergy | 2003

15-Year aeroallergen records. Their usefulness in Athens Olympics, 2004

Dimitrios Gioulekas; Athanasios Damialis; Despoina Papakosta; A. Syrigou; G. Mpaka; F. Saxoni; D. Patakas

Introduction: About 5–25% of 16 000 athletes involved in preparation for the Athens 2004 Olympics may encounter respiratory allergy (asthma and rhinoconjunctivitis) triggered by exposure to aeroallergens (pollen and fungi spores).


European Journal of Internal Medicine | 2011

Bronchoalveolar lavage fluid alteration in antioxidant and inflammatory status in lung cancer patients

Theodoros Kontakiotis; K. Katsoulis; O. Hagizisi; M. Kougioulis; S. Gerou; Despoina Papakosta

BACKGROUND Increased oxidative and inflammatory markers have been reported in lung cancer patients, but relatively few studies have investigated the presence of antioxidants both in the local lung environment and in the systemic circulation. Furthermore, it is hypothesized that the immune system activation in vivo is regulated by the redox environment. OBJECTIVES To investigate local and systemically circulating antioxidant and inflammatory mediators in lung cancer patients and potential correlations between them. METHODS Forty two male patients (mean age 65±8years) with primary lung cancer were studied. Sixteen age and smoking history matched male subjects without any evidence of malignancy served as controls. Total antioxidant status (TAS) and glutathione (GSH), as well as interleukin-1a (IL-1a), interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α) were measured in bronchoalveolar lavage fluid (BALF) and serum samples. RESULTS A statistically significant increase of TAS and GSH in BALF was observed in lung cancer patients compared to healthy subjects (0.27±0.24 vs. 0.12±0.02mmol/L, p=0.02 and 7.56±4.29 vs. 4.62±2.23μmol/L, p=0.01 respectively). Statistically significant correlations in cancer patients were observed in BALF between TAS and a. IL-1α (r=0.87, p<0.001), b. IL-6 (r=0.52, p=0.001) and c. TNF-α (r=0.67, p<0.001). CONCLUSIONS Alteration in antioxidant and inflammatory mediator status was found in lung cancer patients both in serum and in BALF compared to healthy subjects matched for smoking history. Moreover, a positive correlation was observed between antioxidants and pro-inflammatory cytokines, but only locally and not systematically.


Journal of Exposure Science and Environmental Epidemiology | 2017

Is daily exposure to ozone associated with respiratory morbidity and lung function in a representative sample of schoolchildren? Results from a panel study in Greece

Evangelia Samoli; Konstantina Dimakopoulou; Dimitris Evangelopoulos; Sophia Rodopoulou; Anna Karakatsani; Lambrini Veneti; Maria Sionidou; Ioannis Tsolakoglou; Ioanna Krasanaki; Georgios Grivas; Despoina Papakosta; Klea Katsouyanni

Previous time series or panel studies of asthmatics have reported respiratory health effects following short-term exposure to ozone (O3). We followed 186 children aged 10 years old in Athens and Thessaloniki, Greece for 5 weeks during the academic year 2013–2014 and recorded daily their respiratory symptoms, absenteeism and peak expiratory flow (PEF). We applied mixed models controlling for various possible confounders to investigate the daily associations between O3 exposure — derived from weekly personal and fixed school site measurements calibrated using daily values of the fixed monitoring site nearest to the child’s school location — and PEF, presence of any symptom, cough and stuffy nose, as well as absenteeism. We tested the robustness of our findings to varying modeling assumptions and confounders and investigated effect modification patterns by medication use, time spent outdoors and prevalence of asthma. A 10 μg/m3 increase in O3 personal exposure was associated with increased odds of any symptom (odds ratio (OR): 1.19, 95% confidence interval (CI): 0.98, 1.44), largely attributed to the increase in the odds of stuffy nose (OR: 1.23, 95% CI: 1.00, 1.51). PEF and absenteeism were not related to O3 exposure. Our results were robust to several sensitivity analyses. Effects were modified by medication use as presence of symptoms but also decreases in PEF were mainly reported among non-users, while our effect estimates were not driven by the asthmatic subgroup of children. Our findings indicate that short-term O3 exposure may be associated with respiratory symptoms extending previously reported results for asthmatics to the general population.


Respiration | 2009

BRONCHOALVEOLAR LAVAGE FLUID EOSINOPHILS ARE CORRELATED TO NATURAL KILLER CELLS IN EOSINOPHILIC PNEUMONIAS

Despoina Papakosta; Katerina Manika; Georgios Kyriazis; Theodoros Kontakiotis; Dimitrios Gioulekas; T. Polyzoni; Demosthenes Bouros; D. Patakas

Background: Eosinophilic lung diseases comprise a group of heterogeneous pulmonary disorders linked by increased eosinophils in bronchoalveolar lavage fluid (BALF). There is supporting evidence that natural killer (NK) cells participate in the regulation of eosinophilic inflammation. Objective: Our aim was to investigate the relationship between eosinophils and NK cells in BALF in patients with different interstitial lung diseases (ILDs) focusing on eosinophilic pneumonias. Methods: Of 114 patients who presented with increased BALF eosinophils (>5%), 74 patients were classified into the following groups: 27 had eosinophilic pneumonia (EP), 17 had idiopathic pulmonary fibrosis (IPF), 16 had hypersensitivity pneumonitis (HSP) and 14 had cryptogenic organizing pneumonia (COP/BOOP). Total BALF cells, cell density and cell differential counts were assessed and lymphocyte subsets CD3+, CD4+, CD8+, CD19+, CD3–CD16/56+ (NK) and CD3+CD16/56+ (NKT) were determined by flow cytometry. Results: Significant differences were observed in the percentages of lymphocytes (p < 0.001) and CD3+CD16/56+ cells (p = 0.023) among patient groups. In patients with EP, the percentage of eosinophils correlated positively with the number of CD3–CD16/56+ cells (r = 0.522, p = 0.005), the percentage of CD3–CD16/56+ cells (r = 0.690, p < 0.001), and the absolute count of CD3+CD16/56+ absolute cells (r = 0.609, p = 0.001). However, in patients with IPF, HSP or COP/BOOP, no correlation between the percentage of eosinophils and CD3–CD16/56+ or CD3+CD16/56+ cells was observed. Conclusions: Eosinophil inflammation seems to develop through a different pathway in EP compared to other ILDs.


International Journal of General Medicine | 2012

Williams-Campbell syndrome: a case report.

Maria Konoglou; Konstantinos Porpodis; Paul Zarogoulidis; Nikolaos Loridas; Nikolaos Katsikogiannis; Alexandros Mitrakas; Vasilis Zervas; Theodoros Kontakiotis; Despoina Papakosta; Panagiotis Boglou; Stamatia Bakali; Nikolaos Courcoutsakis; Konstantinos Zarogoulidis

Introduction Williams–Campbell syndrome, also known as bronchomalacia, is a rare disorder characterized by a deficiency of cartilage in subsegmental bronchi, leading to distal airway collapse and bronchiectasis. There have been few reports about patients affected by saccular bronchiectasis, paracicatricial emphysema, and diminished cartilage. These are all characteristic of Williams–Campbell syndrome. Case presentation This report presents a 57-year-old woman with progressive dyspnea, cough, sputum production, and fever. The clinical and laboratory examination revealed that the patient had a respiratory infection due to bronchiectasis caused by Williams–Campbell syndrome, which was undiagnosed in the patient until then. Conclusion Although a rare syndrome, when patients’ signs and symptoms include recurrent respiratory infections, bronchiectasis, productive cough, and dyspnea, Williams–Campbell syndrome should be included in the differential diagnosis.


International Journal of General Medicine | 2012

Health costs from hospitalization with H1N1 infection during the 2009-2010 influenza pandemic compared with non-H1N1 respiratory infections.

Paul Zarogoulidis; Dimitrios Glaros; Theodoros Kontakiotis; Marios Froudarakis; loannis Kioumis; loannis Kouroumichakis; Anastasios Tsiotsios; Anastasios Kallianos; Paschalis Steiropoulos; Konstantinos Porpodis; Evagelia Nena; Despoina Papakosta; Aggeliki Rapti; Theodoros C. Constantinidis; Theodora Kerenidi; Maria Panopoulou; Georgia Trakada; Nikolaos Courcoutsakis; Evangelia Fouka; Konstantinos Zarogoulidis; Efstratios Maltezos

Background The first positive patient with influenza A (H1N1) was recorded in March 2009 and the pandemic continued with new outbreaks throughout 2010. This study’s objective was to quantify the total cost of inpatient care and identify factors associated with the increased cost of the 2009–2010 influenza A pandemic in comparison with nonviral respiratory infection. Methods In total, 133 positive and 103 negative H1N1 patients were included from three tertiary care hospitals during the two waves of H1N1 in 2009 and 2010. The health costs for protective equipment and pharmaceuticals and hospitalization (medications, laboratory, and diagnostic tests) were compared between H1N1 positive and negative patients. Results The objective of the study was to quantify the means of daily and total costs of inpatient care. Overall, cost was higher for H1N1 positive (€61,0117.72) than for H1N1-negative patients (€464,923.59). This was mainly due to the protection measures used and the prolonged hospitalization in intensive care units. In H1N1-negative patients, main contributors to cost included additional diagnostic tests due to concern regarding respiratory capacity and laboratory values, as well as additional radiologic and microbial culture tests. The mean duration of hospitalization was 841 days for H1N1 positive and 829 days for negative patients. Conclusion Cost was higher in H1N1 patients, mainly due to the protection measures used and the increased duration of hospitalization in intensive care units. An automated system to monitor patients would be desirable to reduce cost in H1N1 influenza.


Environmental Research | 2017

Determinants of personal exposure to ozone in school children. Results from a panel study in Greece

Konstantina Dimakopoulou; Georgios Grivas; Evangelia Samoli; Sophia Rodopoulou; Dionisis Spyratos; Despoina Papakosta; Anna Karakatsani; Archontoula Chaloulakou; Klea Katsouyanni

Background: In the wider framework of the RESPOZE (ReSPiratory effects of OZone Exposure in Greek children) panel study, we investigated possible determinants of O3 exposure of school children, measured with personal passive samplers, in Athens and Thessaloniki, Greece. Methods: Personal exposure to O3 was measured for five weeks spread along the academic year 2013‐14, in 186 school children in Athens and Thessaloniki, Greece. At the same time, at‐school outdoor measurements were performed and ambient levels of 8‐h daily maximum O3 from fixed sites were collected. We also collected information on lifestyle and housing characteristics through an extended general questionnaire (GQ) and each participant completed daily time activity diaries (TADs) during the study period. Results: Mean outdoor concentrations were higher during the warmer months, in the suburbs of the cities and in Athens. Personal exposure concentrations were significantly lower compared to outdoor. Daily levels of at‐school outdoor and ambient levels of O3 from fixed sites were significant determinants of personal exposure to O3. For a 10 &mgr;g/m3 increase in at‐school outdoor O3 concentrations and PM10 measurements a 20.9% (95% CI: 13%, 28%) increase in personal exposure to O3 was found. For a half an hour more spent in transportation an average increase of 7% (95% CI: 0.3%, 14.6%) in personal exposure to O3 was observed. Among other possible determinants, time spent in transportation (TAD variable) and duration of open windows were the ones associated with personal O3 exposure levels. Conclusions: Our results support the use of outdoor and ambient measurements from fixed sites in epidemiological studies as a proxy of personal exposure to O3, but this has to be calibrated taking into account personal measurements and time‐activity patterns. HighlightsPossible determinants of personal ozone exposure of school children were investigated.Methods rely on personal passive samplers and simultaneously at‐school measurements.Epidemiological studies may use ambient measurements as a proxy for personal exposure.


Case Reports in Ophthalmology | 2011

Exophthalmos as a First Manifestation of Small Cell Lung Cancer: A Long-Term Follow-Up

Maria Konoglou; Pavlos Zarogoulidis; Kostas Porpodis; Sofia Androudi; Despoina Papakosta; Dimitris Matthaios; Theodoros Kontakiotis; Vasilis Zervas; E. Kalaitzidou; A. Mitrakas; P. Touzopoulos; Konstantinos Zarogoulidis

Small cell lung cancer is characterized by rapid growth and early metastasis. Despite its sensitivity to cytotoxic therapy, until now treatments have failed to control or cure this disease in most patients. Οrbital metastases are a rare manifestation of systemic malignancies. Breast and lung cancers represent more than two thirds of the primary cancer sites. Metastases to the eye and orbit develop in approximately 0.7–12% of patients with lung cancer. Here, we report a rare case of exophthalmos as the first manifestation of a metastatic carcinoma due to small cell lung cancer, and a 6-months follow-up with complete exophthalmic response to chemotherapy.

Collaboration


Dive into the Despoina Papakosta's collaboration.

Top Co-Authors

Avatar

Theodoros Kontakiotis

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

Konstantinos Zarogoulidis

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

Konstantinos Porpodis

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

Dimitrios Gioulekas

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

D. Patakas

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

Paul Zarogoulidis

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

Katerina Manika

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

Athanasios Damialis

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

Demosthenes Bouros

Democritus University of Thrace

View shared research outputs
Top Co-Authors

Avatar

Georgios Kyriazis

Aristotle University of Thessaloniki

View shared research outputs
Researchain Logo
Decentralizing Knowledge